{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:18:17Z","timestamp":1794601097694,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijantimicag.2025.107707","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:43:35Z","timestamp":1769701415000},"page":"107707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of intracameral amphotericin B for fungal keratitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-1079","authenticated-orcid":false,"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107707_bib0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12126","article-title":"Mycotic keratitis: epidemiology, diagnosis and management","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/jof7040273","article-title":"Mycotic keratitis\u2014a global threat from the filamentous fungi","volume":"7","author":"Hoffman","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0003","doi-asserted-by":"crossref","first-page":"698780","DOI":"10.3389\/fcimb.2021.698780","article-title":"Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020)","volume":"11","author":"Ahmadikia","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0004","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.survophthal.2021.08.002","article-title":"Fungal keratitis: mechanisms of infection and management strategies","volume":"67","author":"Donovan","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micpath.2016.12.013","article-title":"Pathogenesis of microbial keratitis","volume":"104","author":"Lakhundi","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0006","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/jof7110907","article-title":"Recent perspectives in the management of fungal keratitis","volume":"7","author":"Raj","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0007","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/jof8101067","article-title":"Management of filamentous fungal keratitis: a pragmatic approach","volume":"8","author":"Hoffman","year":"2022","journal-title":"J Fungi"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107707_bib0008","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107707_bib0009","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S1473-3099(20)30448-5","article-title":"The global incidence and diagnosis of fungal keratitis","volume":"21","author":"Brown","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.51329\/mehdiophthal1528","article-title":"Acanthamoeba keratitis: from pathophysiology to prevention, a contemporary clinical perspective","volume":"14","author":"Kiyat","year":"2025","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0011","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4103\/IJO.IJO_2765_24","article-title":"Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis","volume":"73","author":"Singh","year":"2025","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OPTH.S447138","article-title":"Fungal keratitis: diagnosis, management, and recent advances","volume":"18","author":"Awad","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0013","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamaophthalmol.2024.1716","article-title":"Prophylactic intracameral antibiotics and endophthalmitis after cataract surgery","volume":"142","author":"van Rooij","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2025.107707_bib0014","first-page":"885","article-title":"Epidemiological profile of fungal keratitis in South India","volume":"65","author":"Sharma","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes\u2014discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments","volume":"43","author":"Kami\u0144ski","year":"2014","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0017","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1007\/s00210-025-04268-8","article-title":"Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems","volume":"398","author":"Kumar","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0018","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12911-025-03119-z","article-title":"Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? A systematic review and exploratory meta-analysis","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107707_bib0019","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107707_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archophthalmol.2011.303","article-title":"The Steroids for Corneal Ulcers Trial: study design and baseline characteristics","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107707_bib0021","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ophtha.2005.10.063","article-title":"Risk factors for treatment outcome in fungal keratitis","volume":"113","author":"Lalitha","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0022","first-page":"829","article-title":"Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study","volume":"140","author":"Bezerra","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0023","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5935\/0034-7280.20200067","article-title":"Fungal keratitis management in a referral cornea center in Brazil","volume":"79","author":"Bezerra","year":"2020","journal-title":"Rev Bras Oftalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0024","article-title":"An intracameral approach for recalcitrant fungal keratitis","volume":"25","author":"Dong","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0025","first-page":"NC05","article-title":"Early versus delayed intervention with intracameral liposomal amphotericin B in recalcitrant keratomycosis: experience of a large case series","volume":"13","author":"Gupta","year":"2019","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00003226-200110000-00009","article-title":"Intracameral amphotericin B","volume":"20","author":"Kaushik","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0027","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00003226-200210000-00004","article-title":"Intracameral amphotericin B injection in the management of deep keratomycosis","volume":"21","author":"Kuriakose","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0028","first-page":"e20769","article-title":"Postoperative fungal keratitis managed by anterior chamber washout and intracameral amphotericin-B: a report of two cases","volume":"13","author":"Maniam","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107707_bib0029","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1442-9071.2010.02473.x","article-title":"Voriconazole versus natamycin as primary treatment in fungal keratitis","volume":"39","author":"Arora","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/ICO.0000000000003268","article-title":"Repeated intracameral amphotericin B: a safe approach for management of fungal anterior chamber reactivations after therapeutic penetrating keratoplasty","volume":"42","author":"Okonkwo","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0031","first-page":"681","article-title":"A case report of intracameral amphotericin B injection in the management of deep keratomycosis","volume":"45","author":"Park","year":"2004","journal-title":"J Korean Ophthalmol Soc"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0032","first-page":"Doc03","article-title":"Successful treatment of Fusarium solani anterior chamber involvement secondary to contact lens associated corneal ulcer with intracameral amphotericin B","volume":"9","author":"Peters","year":"2019","journal-title":"DOAJ"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0033","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3341\/jkos.2007.48.9.1202","article-title":"Risk factors affecting efficacy of intracameral amphotericin injection in deep keratomycosis","volume":"48","author":"Seo","year":"2007","journal-title":"J Korean Ophthalmol Soc"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0034","first-page":"257","article-title":"Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis","volume":"3","author":"Shao","year":"2010","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajo.2019.03.023","article-title":"Microbial keratitis in Taiwan: a 20-year update","volume":"205","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107707_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2005.08.013","article-title":"Microbial keratitis: predisposing factors and morbidity","volume":"113","author":"Keay","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0037","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ICO.0b013e318030767e","article-title":"Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis","volume":"26","author":"Yilmaz","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0038","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/ICO.0b013e31806c791e","article-title":"Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0039","first-page":"1","article-title":"Combined topical and intracameral injection of amphotericin B versus topical amphotericin B in management of fungal keratitis in MOC, Egypt","volume":"1","author":"Awad","year":"2021","journal-title":"Egypt J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/microorganisms12010161","article-title":"Recent advances in diagnosis and treatment approaches in fungal keratitis: a narrative review","volume":"12","author":"Ghenciu","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2025.107707_bib0041","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","article-title":"The biology of the Cryptococcus neoformans species complex","volume":"60","author":"Lin","year":"2006","journal-title":"Annu Rev Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925002626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925002626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:03:43Z","timestamp":1785755023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925002626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0924857925002626"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107707","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intracameral amphotericin B for fungal keratitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107707"}}